Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.209 USD | +1.33% | +2.26% | -68.53% |
06:44pm | TFF Pharmaceuticals, Leidos to Advance Biodefense Countermeasures Into Preclinical Testing | MT |
05-20 | TFF Pharmaceuticals Advances Influenza Vaccine Candidates Into Preclinical Testing | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
6.75M | - | - | - | |||
62.59B | - | |||||
41.18B | ||||||
40.29B | ||||||
27.9B | ||||||
26.21B |